Signature Wealth Management Group
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1736666
ATLANTA, GA
Position in VRTX
as of Mar 31, 2026
· filed Apr 1, 2026
Position Value
$235,326
-$1,725,002 QoQ
Shares Held
527
-87.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Signature Wealth Management Group holds $1,057,898 across 2 Biotechnology names. VRTX ranks #2 (22.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
15,740 | $822,572 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
527 | $235,326 |
All Filings in VRTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $235,326 | 527 | Shares | Sole | 2026-04-01 | |
| 2025-12-31 | $1,960,328 | 4,324 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,610,032 | 4,111 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,889,428 | 4,244 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $2,044,970 | 4,218 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $1,641,002 | 4,075 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,847,297 | 3,972 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,760,981 | 3,757 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $685,954 | 1,641 | Shares | Sole | 2024-04-22 | |
| No filing history on record for this holder in this stock. | ||||||